Metrika

  • citati u SCIndeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:12
  • preuzimanja u poslednjih 30 dana:7

Sadržaj

članak: 7 od 405  
Back povratak na rezultate
Acta medica Medianae
2022, vol. 61, br. 1, str. 48-53
Uticaj pandemije virusa COVID-19 na učestalost i kliničku prezentaciju dijabetesa tipa 1 kod dece i adolescenata - iskustvo jednog centra
Stanković Sandraa ORCID, Gocić Zlatiborb, Golubović Milanb, Stojković Milicab, Miljković Dušanb, Stajić Suzanab, Ognjanović Anđelab, Topalović Marijac, Cvetković Vesnab, Šaranac Ljiljanaa ORCID, Manojlović Milenab, Živić Sašaa
aKlinički centar Niš, Klinika za dečje interne bolesti + Univerzitet u Nišu, Medicinski fakultet
bKlinički centar Niš, Klinika za dečje interne bolesti
cKlinički centar Niš, Klinika za plućne bolesti

e-adresa: stankovic_sandra@yahoo.com
Ključne reči: COVID-19; deca; DKA
Sažetak
Pandemija virusa COVID-19 drastično je promenila funkcionisanje zdravstvenog sistema. Cilj našeg istraživanja je da prikaže incidenciju i kliničku prezentaciju dece i adolescenata sa novootkrivenim tipom 1 šećerne bolesti (DM tip 1) tokom prve godine pandemije virusa COVID-19 i da dobijene podatke uporedi sa podacima iz prethodnih godina. Tokom ispitivanog perioda, dijagnostikovan je 41 bolesnik. Joint point analizom utvrđen je godišnji porast u periodu od 2007. do 2012. godine (APC 8,94%), praćen smanjenjem broja u periodu od 2012. od 2015. godine (APC 6,88%) i statistički značajnim uvećanjem od 2015. do 2020. godine (APC 14,20%). Broj novoobolele dece tokom prve godine COVID-19 pandemije bio je veći, ali bez statističke značajnosti. Procenat dece sa dijabetesnom ketoacidozom (DKA) u vreme postavljanja dijagnoze DM tip 1, u ispitivanom periodu, bio je značajno veći nego u prethodnim godinama (84,8% prema 34,6%; p < 0,001). Naši rezultati ukazuju na potencijalno dijabetogeni efekat COVID-19 virusa. Potrebne su opsežnije i dugotrajnije studije da bi se utvrdile prave dimenzije ovog uticaja. Drastičan porast DKA u vreme postavljanja dijagnoze DM tip 1, tokom pandemije COVID-19 virusa zahteva poboljšanje preventivnih mera.
Reference

*** (2020) Joinpoint Regression Program (computer program): Version 4.8.0.1. statistical methodology and applications branch, surveillance research program. National Cancer Institute

Dimeglio, L.A., Albanese-O'neill, A., Muñoz, C.E., Maahs, D.M. (2020) COVID-19 and children with diabetes-updates, unknowns, and next steps: First, do no extrapolation. Diabetes Care, 43(11), 2631-2634

Duca, L.M., Wang, B., Rewers, M., Rewers, A. (2017) Diabetic ketoacidosis at diagnosis of type 1 diabetes predicts poor long-term glycemic control. Diabetes Care, 40(9), 1249-1255

EURODIAB Substudy 2 Study Group (2002) Rapid early growth is associated with increased risk of childhood type 1 diabetes in various European populations. Diabetes Care, 25(10), 1755-1760

European Centre for Disease Prevention and Control (2021) Data on 14-day notification rate of new COVID-19 cases and deaths. 2021 april 22nd 'cited 2021 april 22nd ', https://www.ecdc.europa.eu/en/publicationsdata/data-national-14-day-notification-rate-covid-19

Fu, J., Zhou, B., Zhang, L., Balaji, K.S., Wei, C., Liu, X., et al. (2020) Expressions and significances of the angiotensinconverting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19. Mol Biol Rep, 14, 1-10

Ho, J., Rosolowsky, E., Pacaud, D., Huang, C., Lemay, J.A., Brockman, N., et al. (2021) Diabetic ketoacidosis at type 1 diabetes diagnosis in children during the COVID-19 pandemic. Pediatr Diabetes, 1-6

9

International Diabetes Federation (2017) IDF diabetes atlas. Brussels: International Diabetes Federation, 8th edition

Ješić, M.D., Ješić, M.M., Stanisavljević, D., Zdravković, V., Bojić, V., Vranješ, M. (2013) Ketoacidosis at presentation of type 1 diabetes mellitus in children: A retrospective 20-year experience from a tertiary care hospital in Serbia. Eur J Pediatr, 172(12), 1581-1585

Li, M.Y., Li, L.Y., Zhang, Y., Wang, X.S. (2020) Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infectious Diseases of Poverty, 9(1), 45

Sipetić, S., Maksimović, J., Vlajinac, H., Ratkov, I., Sajić, S., Zdravković, D. (2005) Rising incidence of type 1 diabetes in Belgrade children aged 0-14 years in the period from 1982 to. J Endocrinol Investig, 36, 307-312

Stanković, S., Vuković, R., Vorgucin, I., Zdravković, V., Folić, N., Živić, S. (2021) First report on the nationwide prevalence of paediatric type 1 diabetes in Serbia and temporal trends of diabetes ketoacidosis at diagnosis-a multicentre study. Journal of Pediatric Endocrinology and Metabolism, 34(2), 225-229

The Diamond Project Group (2006) Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med, 23, 857-866

Tittel, S.R., Rosenbauer, J., Kamrath, C., Ziegler, J., Reschke, F., Hammersen, J., Mönkemöller, K., Pappa, A., Kapellen, T., Holl, R.W. (2020) Did the COVID-19 lockdown affect the incidence of pediatric type 1 diabetes in Germany?. Diabetes Care, 43(11), e172-e173

Unsworth, R., Wallace, S., Oliver, N.S., Yeung, S., Kshirsagar, A., Naidu, H., Kwong, R.M.W., Kumar, P., Logan, K.M. (2020) New-onset type 1 diabetes in children during COVID-19: Multicenter regional findings in the U.K. Diabetes Care, 43(11), e170-e171

Vuković, R., Ješić, M.D., Vorgucin, I., Stanković, S., Folić, N., Milenković, T. (2018) First report on the nationwide incidence of type 1 diabetes and ketoacidosis at onset in children in Serbia: A multicenter study. European Journal of Pediatrics, 177(8), 1155-1162

1

Wolfsdorf, J.I., Glaser, N., Agus, M., Fritsch, M., Hanas, R., Rewers, A., Sperling, M.A., Codner, E. (2018) ISPAD clinical practice consensus guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatric Diabetes, 19, 155-177

Yang, L., Han, Y., Nilsson-Payant, B.E., Gupta, V., Wang, P., Duan, X., et al. (2020) A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell Stem Cell, 27, 125-36.e7

You, W.P., Henneberg, M. (2016) Type 1 diabetes prevalence increasing globally and regionally: the role of natural selection and life expectancy at birth. BMJ Open Diabetes Research & Care, 4(1), e000161
   

O članku

jezik rada: engleski
vrsta rada: originalan članak
DOI: 10.5633/amm.2022.0107
objavljen u SCIndeksu: 15.04.2022.
metod recenzije: dvostruko anoniman
Creative Commons License 4.0

Povezani članci

Vojnosanitetski pregled (2016)
Neke specifičnosti glikemijske kontrole kod dijabetičara sa dijabetesnom bolesti bubrega
Dragović Tamara, i dr.

Vojnosanitetski pregled (2020)
Efekat vitamina D na proteinuriju, lipidni status, glikoregulaciju i C-reaktivni protein kod bolesnika sa dijabetes melitusom tip 2
Petrović Marijana, i dr.

Vojnosanitetski pregled (2022)
Detekcija dijabetesne polineuropatije u ambulanti porodične medicine korišćenjem monofilamenta
Lakić Biljana, i dr.

prikaži sve [10]